Litigation Details for Spectrum Pharmaceuticals Incorporated v. Lachman Consulting Services, Incorporated (C.D. Cal. 2014)
✉ Email this page to a colleague
Spectrum Pharmaceuticals Incorporated v. Lachman Consulting Services, Incorporated (C.D. Cal. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-09-22 |
| Court | District Court, C.D. California | Date Terminated | |
| Cause | 28:1332 Diversity-Fraud | Assigned To | Michael Walter Fitzgerald |
| Jury Demand | Plaintiff | Referred To | Magistrate Judge Margaret A. N |
| Patents | 6,500,829 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Spectrum Pharmaceuticals Incorporated v. Lachman Consulting Services, Incorporated
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Spectrum Pharmaceuticals Incorporated v. Lachman Consulting Services, Incorporated (C.D. Cal. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-09-22 | 1 | SPECTRUM is the exclusive licensee to U.S. Patent No. 6,500,829, 5 entitled “Substantially Pure Diastereoisomers…infringe upon the ‘829 Patent. ln addition, SPECTRUM sought a declaration that ‘829 Patent was valid and enforceable…infringe upon the ‘829 Patent. In addition, SPECTRUM sought a declaration that ‘829 Patent was Valid and enforceable…infringe upon the ‘829 Patent. In addition, SPECTRUM sought a declaration that ‘829 Patent was valid and enforceable…regulatory matters as Well as the resolution of patent and exclusivity issues. JURISDICTION 5. This | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
